% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Goldschmid:275795,
author = {H. Goldschmid and K. Kluck and M. Ball and M. Kirchner and
M. Allgäuer and H. Winter and F. Herth and C.-P. Heußel
and S. S. Pullamsetti and R. Savai and T. T. K. Yong and P.
Schirmacher$^*$ and S. Peters and M. Thomas and P.
Christopoulos and J. Budczies$^*$ and A. Stenzinger$^*$ and
D. Kazdal},
title = {{S}patial profiling of the microenvironment reveals low
intratumoral heterogeneity and {STK}11-associated immune
evasion in therapy-naïve lung adenocarcinomas.},
journal = {Lung cancer},
volume = {180},
issn = {0169-5002},
address = {Amsterdam [u.a.]},
publisher = {Elsevier},
reportid = {DKFZ-2023-00883},
pages = {107212},
year = {2023},
abstract = {Intratumoral heterogeneity was found to be a significant
factor causing resistance to lung cancer therapies,
including immune checkpoint blockade. Lesser is known about
spatial heterogeneity of the tumor microenvironment (TME)
and its association with genetic properties of the tumor,
which is of particular interest in the therapy-naïve
setting.We performed multi-region sampling (2-4 samples per
tumor; total of 55 samples) from a cohort of 19 untreated
stage IA-IIIB lung adenocarcinomas (n = 11 KRAS mutant,
n = 1 ERBB2 mutant, n = 7 KRAS wildtype). For each
sample the expression of 770 immunooncology-related genes
was analyzed using the nCounter platform, while the
mutational status was determined by hybrid capture-based
next-generation sequencing (NGS) using a large panel
covering more than 500 genes.Global unsupervised analyses
revealed clustering of the samples into two groups
corresponding to a 'hot' or 'cold' immunologic tumor
contexture based on the abundance of immune cell
infiltrates. All analyzed specific immune cell signatures
(ICsig) showed a significantly higher intertumoral than
intratumoral heterogeneity (p < 0.02), as most of the
analyzed cases (14/19) showed a very homogenous spatial
immune cell profile. PD-L1 exhibited a significantly higher
intertumoral than intratumoral heterogeneity
(p = 1.03e-13). We found a specific association with
'cold' TME for STK11 (11/14, p < 0.07), but not KRAS,
TP53, LRP1B, MTOR, U2AF1 co-mutations, and validated this
finding using The Cancer Genome Atlas (TCGA)
data.Early-stage lung adenocarcinomas show considerable
intertumoral, but limited intratumoral heterogeneity, which
is clinically highly relevant as assessment before
neoadjuvant treatment is based on small biopsies. STK11
mutations are specifically associated with a 'cold' TME,
which could affect the efficacy of perioperative
immunotherapy.},
keywords = {Intertumoral heterogeneity (Other) / Lung adenocarcinoma
(Other) / STK11 (Other) / TME (Other) / Tumor
microenvironment (Other)},
cin = {HD01},
ddc = {610},
cid = {I:(DE-He78)HD01-20160331},
pnm = {899 - ohne Topic (POF4-899)},
pid = {G:(DE-HGF)POF4-899},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:37141769},
doi = {10.1016/j.lungcan.2023.107212},
url = {https://inrepo02.dkfz.de/record/275795},
}